The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation of histopathologic regression with progression free survival (PFS) in patients (pts) with RAS wildtype metastatic colorectal cancer (mCRC) under fluorouracil/folinic acid, irinotecan, and oxaliplatin (FOLFOXIRI) plus panitumumab (pmab) or FOLFOXIRI alone: Subgroup analysis of VOLFI (AIO-KRK-0109).
 
Stefanie Noepel-Duennebacke
Consulting or Advisory Role - Baxalta; Bristol-Myers Squibb
Research Funding - Celgene (Inst); Ipsen (Inst); Roche (Inst); Sanofi/Aventis (Inst)
Travel, Accommodations, Expenses - Ipsen
 
Hendrik Juette
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; MSD; Roche
 
Celine Lugnier
No Relationships to Disclose
 
Michael Geissler
No Relationships to Disclose
 
Uwe Marc Martens
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; MSD Oncology; Roche
Travel, Accommodations, Expenses - Amgen
 
Volker Heinemann
Honoraria - Amgen; Baxalta; Boehringer Ingelheim; Celgene; Lilly; Merck; Roche; Sanofi; SERVIER; Sirtex Medical; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Baxalta; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Halozyme; Merck; MSD; Roche; Sanofi; SERVIER; Sirtex Medical
Research Funding - Amgen (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Merck (Inst); Roche (Inst); Shire (Inst); Sirtex Medical (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; MSD; Roche; SERVIER; Shire; Sirtex Medical
 
Swantje Held
No Relationships to Disclose
 
Renate Klaassen-Mielke
No Relationships to Disclose
 
Dominik Paul Modest
Honoraria - Amgen; Bristol-Myers Squibb; Merck Serono; Pfizer; Roche; SERVIER; Sirtex Medical
Consulting or Advisory Role - Amgen; Bayer; Merck Serono
Research Funding - Amgen (Inst); Merck Serono (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Bristol-Myers Squibb; Merck Serono; SERVIER
 
Anke C. Reinacher-Schick
Honoraria - Amgen; Baxalta; Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; MSD; Pfizer; Roche; Sanofi/Aventis; SERVIER; Shire
Consulting or Advisory Role - Amgen; Baxalta; Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; MSD; Pfizer; Roche; Sanofi/Aventis; SERVIER
Research Funding - Celgene; Ipsen; Roche; Sanofi/Aventis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen
 
Thomas Seufferlein
Honoraria - Amgen; Bayer Schering Pharma; Celgene; Falk Foundation; Merck Serono; Roche; Sanofi
Consulting or Advisory Role - Boehringer Ingelheim; Celgene; Lilly; Merck Serono
Research Funding - Celgene; Sanofi
Travel, Accommodations, Expenses - Bayer Schering Pharma; Celgene; Merck Serono; Roche; Sanofi
 
Andrea Tannapfel
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; Pfizer; Roche; Sanofi/Aventis; Shire
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; Pfizer; Roche; Sanofi/Aventis
Research Funding - Celgene; Ipsen; Roche; Sanofi/Aventis